Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.
The observed reduction in VT-carriage amongst Indian children was comparable to that observed with other PCVs that have demonstrated marked declines in disease transmission. These results suggest PNEUMOSIL® could be an effective public health tool in decreasing pneumococcal disease.
Authors
- C. Poonawalla
- Y. A. Tang
- A. Apte
- A. Jadhav
- A. Kawade
- R. Nerlekar
- S. Sanghavi
- A. Bavdekar
- V. Sethna
- W.P. Hausdorff
- R. Dhere
- G. Dayma
- R. Tuttle
Institutions
- Program for Appropriate Technology in Health (US)
- Serum Institute of India (India) (IN)
- College of Medicine & JNM Hospital (IN)
- keiyu Hospital (JP)
- CM Hospital (KR)
Publication Details
- Journal
- Vaccine
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1016/j.vaccine.2025.128129
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00